Hycamtin® (topotecan HCl) Indication Expanded To Include Treatment Of Cervical Cancer In Combination With Chemotherapy

Fri, 08 Dec 2006 02:00 PM EST

... GlaxoSmithKline plc announced today that the European Medicines Agency (EMEA) has granted Marketing Authorisation for HYCAMTIN® (topotecan HCl) in combination with cisplatin, for the treatment of patients with carcinoma of the cervix recurrent after radiotherapy and for patients with Stage IVB disease. [click link for full article] ...